Search real jobs
Live openings scraped directly from company career pages, with ghost-job checks built in. Search free, no account needed.
Live openings scraped directly from company career pages, with ghost-job checks built in. Search free, no account needed.
Live openings scraped directly from company career pages, with ghost-job checks built in. Search free, no account needed.
Save this search
Get the top new matches for it emailed to you every week.
Showing 1 to 18 of 18
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy
Save your search for weekly matches, then practice voice mock interviews and tailor your resume to the exact job description.